1. Medtech Insight

Sectra signs up Spanish distributor of mammography tech - UPDATE

 
• By Madeleine Armstrong

Swedish medical image management company Sectra has signed up Fundaci�n García Muñoz (FGM) as the non-exclusive distributor of its full range of digital mammography technology in Spain. The deal, of which financial details were not disclosed, will see FGM make technology such as Sectra’s MicroDose mammography and breast imaging PACS system available to both the private and public healthcare sectors in the country. Torbjörn Kronander, president of Sectra Imtec, told Clinica that the digital mammography market in Spain was among the top five largest markets in Europe along with the UK, Germany, France and Italy.

Swedish medical image management company Sectra has signed up Fundaci�n García Muñoz (FGM) as the non-exclusive distributor of its full range of digital mammography technology in Spain. The deal, of which financial details were not disclosed, will see FGM make technology such as Sectra’s MicroDose mammography and breast imaging PACS system available to both the private and public healthcare sectors in the country. Torbjörn Kronander, president of Sectra Imtec, told Clinica that the digital mammography market in Spain was among the top five largest markets in Europe along with the UK, Germany, France and Italy.

* In other news, the South East Trust in Northern Ireland, a network of hospitals using Sectra’s PACS technology, has...

More from Archive

More from Medtech Insight

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 
• By Natasha Barrow

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.

SS Innovations’ SSI Mantra 3 Poised To Challenge Da Vinci In Robotic Surgery Market

 
• By Marion Webb

SS Innovations reported its first SSi Mantra 3 robotic cardiac surgery in South America as it prepares to file for US FDA de novo clearance and a CE mark. The firm aims to challenge Intuitive Surgical with a lower-cost, flexible system targeting US and European markets.

Innovative Wants Injunction Against J&J Subsidiary After $442M Antitrust Verdict

 
• By Elizabeth Orr

Innovative Healthcare is asking for a permanent injunction against Johnson & Johnson subsidiary Biosense Webster after winning a $442 million antitrust verdict. The injunction aims to prevent continued anticompetitive practices in the electrophysiology catheter market.